glp 1 clinical trials sign up Boston biotech secures Series A funding to move its once-weekly GLP-1 obesity patch into first-in-human trials. ㅤ Link in bio. ㅤ #longevity #obesity #glp1 #clinicaltrials #biotech Inside the GLP-1 Clinical Trials:

(Eli Lily, 2026)

Starting doses for tirzepatide are typically 2.5 mg per week, administered as a subcutaneous injection

In energy-demanding RGCs, while basal mitophagy is physiologically essential, excessive activation can lead to energy depletion and cellular demise

Only with caution

Peptidtherapie bei Clinic X medizinisch begleitet und individuell eingeordnet Peptide wie GHK-Cu zeigen in der Forschung ein interessantes Potenzial, insbesondere im Zusammenhang mit Regeneration, Hautstruktur und altersbedingten Vernderungen biologischer Prozesse

Striatum quinolinic acid not only increases intracellular Ca 2+ and promotes oxidative stress but also activates different cell death mechanisms by reducing Bcl-2 expression and increasing JNK activity [88]